These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 23737838)
1. Resveratrol Impedes the Stemness, Epithelial-Mesenchymal Transition, and Metabolic Reprogramming of Cancer Stem Cells in Nasopharyngeal Carcinoma through p53 Activation. Shen YA; Lin CH; Chi WH; Wang CY; Hsieh YT; Wei YH; Chen YJ Evid Based Complement Alternat Med; 2013; 2013():590393. PubMed ID: 23737838 [TBL] [Abstract][Full Text] [Related]
3. Cancer stem-like cell characteristics induced by EB virus-encoded LMP1 contribute to radioresistance in nasopharyngeal carcinoma by suppressing the p53-mediated apoptosis pathway. Yang CF; Peng LX; Huang TJ; Yang GD; Chu QQ; Liang YY; Cao X; Xie P; Zheng LS; Huang HB; Cai MD; Huang JL; Liu RY; Zhu ZY; Qian CN; Huang BJ Cancer Lett; 2014 Mar; 344(2):260-71. PubMed ID: 24262659 [TBL] [Abstract][Full Text] [Related]
4. Glutathione metabolism is essential for self-renewal and chemoresistance of pancreatic cancer stem cells. Jagust P; Alcalá S; Sainz Jr B; Heeschen C; Sancho P World J Stem Cells; 2020 Nov; 12(11):1410-1428. PubMed ID: 33312407 [TBL] [Abstract][Full Text] [Related]
5. CD44 and CD24 coordinate the reprogramming of nasopharyngeal carcinoma cells towards a cancer stem cell phenotype through STAT3 activation. Shen YA; Wang CY; Chuang HY; Hwang JJ; Chi WH; Shu CH; Ho CY; Li WY; Chen YJ Oncotarget; 2016 Sep; 7(36):58351-58366. PubMed ID: 27521216 [TBL] [Abstract][Full Text] [Related]
6. CD44 is associated with the aggressive phenotype of nasopharyngeal carcinoma through redox regulation. Lin CH; Hung PH; Chen YJ Int J Mol Sci; 2013 Jun; 14(7):13266-81. PubMed ID: 23803658 [TBL] [Abstract][Full Text] [Related]
7. Oncogenic Metabolism Acts as a Prerequisite Step for Induction of Cancer Metastasis and Cancer Stem Cell Phenotype. Lee SY; Ju MK; Jeon HM; Lee YJ; Kim CH; Park HG; Han SI; Kang HS Oxid Med Cell Longev; 2018; 2018():1027453. PubMed ID: 30671168 [TBL] [Abstract][Full Text] [Related]
8. Pin2 telomeric repeat factor 1-interacting telomerase inhibitor 1 (PinX1) inhibits nasopharyngeal cancer cell stemness: implication for cancer progression and therapeutic targeting. Yu C; Chen F; Wang X; Cai Z; Yang M; Zhong Q; Feng J; Li J; Shen C; Wen Z J Exp Clin Cancer Res; 2020 Feb; 39(1):31. PubMed ID: 32028978 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of mitochondrial cyclooxygenase-2 inhibits the stemness of nasopharyngeal carcinoma by decreasing the activity of dynamin-related protein 1. Zhou TJ; Zhang SL; He CY; Zhuang QY; Han PY; Jiang SW; Yao H; Huang YJ; Ling WH; Lin YC; Lin ZN Theranostics; 2017; 7(5):1389-1406. PubMed ID: 28435473 [TBL] [Abstract][Full Text] [Related]
10. Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin). Martin-Castillo B; Oliveras-Ferraros C; Vazquez-Martin A; Cufí S; Moreno JM; Corominas-Faja B; Urruticoechea A; Martín ÁG; López-Bonet E; Menendez JA Cell Cycle; 2013 Jan; 12(2):225-45. PubMed ID: 23255137 [TBL] [Abstract][Full Text] [Related]
11. EB-virus latent membrane protein 1 potentiates the stemness of nasopharyngeal carcinoma via preferential activation of PI3K/AKT pathway by a positive feedback loop. Yang CF; Yang GD; Huang TJ; Li R; Chu QQ; Xu L; Wang MS; Cai MD; Zhong L; Wei HJ; Huang HB; Huang JL; Qian CN; Huang BJ Oncogene; 2016 Jun; 35(26):3419-31. PubMed ID: 26568302 [TBL] [Abstract][Full Text] [Related]
12. miR-125a is upregulated in cancer stem-like cells derived from TW01 and is responsible for maintaining stemness by inhibiting p53. Chen J; Ouyang H; An X; Liu S Oncol Lett; 2019 Jan; 17(1):87-94. PubMed ID: 30655742 [TBL] [Abstract][Full Text] [Related]
13. Epigallocathechin gallate, polyphenol present in green tea, inhibits stem-like characteristics and epithelial-mesenchymal transition in nasopharyngeal cancer cell lines. Lin CH; Shen YA; Hung PH; Yu YB; Chen YJ BMC Complement Altern Med; 2012 Oct; 12():201. PubMed ID: 23110507 [TBL] [Abstract][Full Text] [Related]
14. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Chang CJ; Chao CH; Xia W; Yang JY; Xiong Y; Li CW; Yu WH; Rehman SK; Hsu JL; Lee HH; Liu M; Chen CT; Yu D; Hung MC Nat Cell Biol; 2011 Mar; 13(3):317-23. PubMed ID: 21336307 [TBL] [Abstract][Full Text] [Related]
15. Targeting redox regulation and autophagy systems in cancer stem cells. Khan SU; Rayees S; Sharma P; Malik F Clin Exp Med; 2023 Sep; 23(5):1405-1423. PubMed ID: 36473988 [TBL] [Abstract][Full Text] [Related]
16. Elevated level of mitochondrial reactive oxygen species via fatty acid β-oxidation in cancer stem cells promotes cancer metastasis by inducing epithelial-mesenchymal transition. Wang C; Shao L; Pan C; Ye J; Ding Z; Wu J; Du Q; Ren Y; Zhu C Stem Cell Res Ther; 2019 Jun; 10(1):175. PubMed ID: 31196164 [TBL] [Abstract][Full Text] [Related]
17. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells. Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337 [No Abstract] [Full Text] [Related]
18. P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs. Zhao Y; Li Y; Sheng J; Wu F; Li K; Huang R; Wang X; Jiao T; Guan X; Lu Y; Chen X; Luo Z; Zhou Y; Hu H; Liu W; Du B; Miao S; Cai J; Wang L; Zhao H; Ying J; Bi X; Song W J Exp Clin Cancer Res; 2019 Aug; 38(1):379. PubMed ID: 31455383 [TBL] [Abstract][Full Text] [Related]
19. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis. Yu CC; Chen PN; Peng CY; Yu CH; Chou MY Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999 [TBL] [Abstract][Full Text] [Related]
20. An integrated analysis to predict micro-RNAs targeting both stemness and metastasis in human gastric cancer. Azimi M; Totonchi M; Rahimi M; Firouzi J; Sahranavard P; Emami Razavi A; Memari F; Kamali F; Ebrahimi M J Gastroenterol Hepatol; 2021 Feb; 36(2):436-445. PubMed ID: 32633423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]